Novartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...

President Trump is set to announce new agreements Friday aimed at lowering prescription drug prices, with major drugmakers like AbbVie, Bri...

Novartis is acquiring U.S. biotech firm Avidity Biosciences for approximately $12 billion in cash to expand its rare disease treatment port...

Novartis has entered into a licensing and options agreement with Argo Biopharmaceutical, valued at up to $5.2 billion. The deal encompasses...

"While the exact revenue from Entresto-related supplies is undisclosed, it contributes a meaningful share to the overall business. However,...

Novartis said in an emailed statement it had made good progress in implementing its new organisational structure that involved integrating ...

In an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global ex...

Swiss drugmaker Novartis is turning to tech to deal with the pharma business in times of pandemic, as companies go virtual. Bertrand Bodson...

With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.

The stock had ended 15.72 per cent in previous trade following media reports that “Novartis AG was planning to delist Indian units.

The collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.

The Indian subsidiary of Swiss drug maker Novartis has dismissed some 18 middle-level sales executives for fabricating and inflating the sa...

If Novartis had won the case, it would have been granted a monopoly on Glivec, and denied Indian companies the right to make the drug.

Mylan has sued USFDA for not allowing it to market a generic version of medicine Diovan, saying that Ranbaxy has lost its exclusivity for t...

Shares of multinational pharmaceutical companies on Wednesday extended gains on the BSE, cheering their parents’ move to hike stake in thes...

Novartis headquarters in Basel is still digesting the rejection of pharma giant’s appeal in the Madras High Court. A press release from Nov...

The news that the Madras High Court has rejected the appeal by the Swiss pharma giant Novartis challenging the constitutionality of section...